SPRR2F | Small proline-rich protein 2F | | | | | | Group enriched |
WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | Predicted secreted proteins
| | | | | Tissue enriched |
ECEL1 | Endothelin converting enzyme-like 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
C4BPB | Complement component 4 binding protein, beta | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
NXPH2 | Neurexophilin 2 | Predicted secreted proteins
| | | | | Group enriched |
PROK1 | Prokineticin 1 | Predicted secreted proteins
| | | | | Group enriched |
KLHDC8A | Kelch domain containing 8A | | | | | | Tissue enriched |
ANGPTL5 | Angiopoietin-like 5 | Predicted secreted proteins
| | | | | Tissue enriched |
HTR1A | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
LRRTM3 | Leucine rich repeat transmembrane neuronal 3 | Predicted membrane proteins
| | | | | Group enriched |
LHX9 | LIM homeobox 9 | Transcription factors
| | | | | Group enriched |
CRYGD | Crystallin, gamma D | Disease related genes
| | | | | Tissue enriched |
FOXL2 | Forkhead box L2 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
MUM1L1 | Melanoma associated antigen (mutated) 1-like 1 | | | | | | Tissue enriched |
FRRS1L | Ferric-chelate reductase 1-like | Predicted membrane proteins
| | | | | Group enriched |
GPR78 | G protein-coupled receptor 78 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
MAG | Myelin associated glycoprotein | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
SPOCK3 | Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 | Predicted secreted proteins
| | | | | Group enriched |
C3orf72 | Chromosome 3 open reading frame 72 | | | | | | Group enriched |
FSHR | Follicle stimulating hormone receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
PPP4R4 | Protein phosphatase 4, regulatory subunit 4 | | | | | | Group enriched |
PTCH2 | Patched 2 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Group enriched |
RHBG | Rh family, B glycoprotein (gene/pseudogene) | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
ARX | Aristaless related homeobox | Disease related genes Plasma proteins Transcription factors
| | | | | Group enriched |
EPHA5 | EPH receptor A5 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
FHL2 | Four and a half LIM domains 2 | | | | | | Group enriched |
GPR88 | G protein-coupled receptor 88 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
NR5A1 | Nuclear receptor subfamily 5, group A, member 1 | Disease related genes Nuclear receptors Transcription factors
| | | | | Group enriched |
SIGLEC11 | Sialic acid binding Ig-like lectin 11 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SLC4A3 | Solute carrier family 4 (anion exchanger), member 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
USP6 | Ubiquitin specific peptidase 6 (Tre-2 oncogene) | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
ZIM2 | Zinc finger, imprinted 2 | Transcription factors
| | | | | Group enriched |
ABCA10 | ATP-binding cassette, sub-family A (ABC1), member 10 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCA9 | ATP-binding cassette, sub-family A (ABC1), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AC091801.1 | LOC392621; Uncharacterized protein | | | | | | Tissue enhanced |
ACSM3 | Acyl-CoA synthetase medium-chain family member 3 | Enzymes Mitochondrial proteins
| | | | | Tissue enhanced |
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS16 | ADAM metallopeptidase with thrombospondin type 1 motif, 16 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADRB3 | Adrenoceptor beta 3 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
AJAP1 | Adherens junctions associated protein 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
AMHR2 | Anti-Mullerian hormone receptor, type II | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ANGPT4 | Angiopoietin 4 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ASIP | Agouti signaling protein | Predicted secreted proteins
| | | | | Tissue enhanced |
BAMBI | BMP and activin membrane-bound inhibitor | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
BNC2 | Basonuclin 2 | Transcription factors
| | | | | Tissue enhanced |
C21orf62 | Chromosome 21 open reading frame 62 | Predicted secreted proteins
| | | | | Tissue enhanced |
C8orf49 | Chromosome 8 open reading frame 49 | Predicted membrane proteins
| | | | | Tissue enhanced |
C9orf147 | Chromosome 9 open reading frame 147 | | | | | | Tissue enhanced |
CAMK1G | Calcium/calmodulin-dependent protein kinase IG | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |